Search Within

Neuroradiology Service

  1. "Early Drug Development Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (9)
  2. Early Drug Development Service (9)
  3. Radiology, Department of (9)
  4. Solid Tumor Oncology Division (9)
  5. GSK Faculty (7)
  6. Human Oncology and Pathogenesis Program (6)

More Groups

People
  1. David Hyman (9)
  2. Eli Diamond (5)
  3. Robert Young (5)
  4. Omar Abdel-Wahab (4)
  5. Raajit Rampal (4)
  6. Vaios Hatzoglou (4)

More People

Years
  1. 2020 (2)
  2. 2019 (4)
  3. 2018 (1)
  4. 2016 (1)
  5. 2015 (1)
Publications
  1. JCO Precision Oncology (3)
  2. Clinical Cancer Research (1)
  3. Nature (1)
  4. Neuro-Oncology (1)
  5. Orphanet Journal of Rare Diseases (1)
  6. Pediatric Blood and Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. Biomed Central Ltd (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)
  6. Radiological Society of North America, Inc. (1)

More Publishers

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of HER2-positive metastases in patients with HER2-negative primary breast cancer by using HER2-targeted (89)Zr-pertuzumab PET/CT
    Journal Article

    Ulaner, G. A.; Carrasquillo, J. A.; Riedl, C. C.; Yeh, R.; Hatzoglou, V.; Ross, D. S.; Jhaveri, K.; Chandarlapaty, S.; Hyman, D. M.; Zeglis, B. M.; more...
    Radiology (2020)

    Fulltext@MSK | Save
  • Neurologic and oncologic features of Erdheim-Chester disease: A 30-patient series
    Journal Article

    Bhatia, A.; Hatzoglou, V.; Ulaner, G.; Rampal, R.; Hyman, D. M.; Abdel-Wahab, O.; Durham, B. H.; Dogan, A.; Ozkaya, N.; Yabe, M.; more...
    Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Response to selective RET inhibition with LOXO-292 in a patient with RET fusion-positive lung cancer with leptomeningeal metastases
    Journal Article

    Guo, R.; Schreyer, M.; Chang, J. C.; Rothenberg, S. M.; Henry, D.; Cotzia, P.; Kris, M. G.; Rekhtman, N.; Young, R. J.; Hyman, D. M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
    Journal Article

    Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Larotrectinib demonstrates CNS efficacy in TRK fusion-positive solid tumors
    Journal Article

    Rosen, E. Y.; Schram, A. M.; Young, R. J.; Schreyer, M. W.; Hechtman, J. F.; Shu, C. A.; Ku, N. C.; Hyman, D. M.; Drilon, A.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of MEK inhibition in patients with histiocytic neoplasms
    Journal Article

    Diamond, E. L.; Durham, B. H.; Ulaner, G. A.; Drill, E.; Buthorn, J.; Ki, M.; Bitner, L.; Cho, H.; Young, R. J.; Francis, J. H.; more...
    Nature (2019)

    Fulltext@MSK | Save
  • Genomic heterogeneity underlies mixed response to tropomyosin receptor kinase inhibition in recurrent glioma
    Journal Article

    Schram, A. M.; Jonsson, P.; Drilon, A.; Bale, T. A.; Hechtman, J. F.; Benayed, R.; Hanusch, B.; Young, R. J.; Grommes, C.; Ku, N.; more...
    JCO Precision Oncology (2018)

    Fulltext@MSK | Save
  • Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Hatzoglou, V.; Patel, S.; Abdel-Wahab, O.; Rampal, R.; Hyman, D. M.; Holodny, A. I.; Raj, A.
    Orphanet Journal of Rare Diseases (2016)

    Fulltext@MSK | Save
  • Diffuse loss of cerebral grey matter structures in Erdheim-Chester disease
    Meeting Abstract

    Diamond, E. L.; Hatzoglou, V.; Pandya, S.; Abdel-Wahab, O.; Hyman, D. M.; Rampal, R.; Raj, A.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save